[1]HAN J,WON M,KIM JH,et al.Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective［J］.Chem Soc Rev,2020,49(22)：7856-7878.
[2]TIRINATO L,LIBERALE C,DI FRANCO S,et al.Lipid droplets：a new player in colorectal cancer stem cells unveiled by spectroscopic imaging［J］.Stem Cells,2015,33(1)：35-44.
[3]PETAN T,JARC E,JUSOVIC M.Lipid droplets in cancer：guardians of fat in a stressful world［J］.Molecules,2018,23(8):1941.
[4]MARTIN S.Caveolae,lipid droplets,and adipose tissue biology：pathophysiological aspects［J］.Horm Mol Biol Clin Investig,2013,15(1)：11-18.
[5]WILFLING F,THIAM AR,OLARTE MJ,et al.Arf1/COPI machinery acts directly on lipid droplets and enables their connection to the ER for protein targeting［J］.Elife,2014,3：e01607.
[6]WANG G,XU J,ZHAO J,et al.Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice［J］.Nat Commun,2020,11(1)：220.
[7]CARRACEDO A,CANTLEY LC,PANDOLFI PP.Cancer metabolism：fatty acid oxidation in the limelight［J］.Nat Rev Cancer,2013,13(4)：227-232.
[8]PARK JH,VITHAYATHIL S,KUMAR S,et al.Fatty acid oxidation-driven src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer［J］.Cell Rep,2016,14(9)：2154-2165.
[9]CHEN CL,UTHAYA KUMAR DB,PUNJ V,et al.NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism［J］.Cell Metab,2016,23(1)：206-219.
[10]LIU S,CHENG K,ZHANG H,et al.Methylation status of the nanog promoter determines the switch between cancer cells and cancer stem cells［J］.Adv Sci(Weinh),2020,7(5)：1903035.
[11]LO REO,DOUET J,BUSCHBECK M,et al.Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells［J］.Epigenetics,2018,13(8)：829-845.
[12]ZHANG C,YUE C,HERRMANN A,et al.STAT3 activation-induced fatty acid oxidation in CD8(+)T effector cells is critical for obesity-promoted breast tumor growth［J］.Cell Metab,2020,31(1)：148-161.
[13]LI W,ZHANG Q,CHEN K,et al.2-Ethoxystypandrone,a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum,inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells［J］.BMC Complement Altern Med,2019,19：38.
[14]YASUMOTO Y,MIYAZAKI H,VAIDYAN LK,et al.Inhibition of fatty acid synthase decreases expression of stemness markers in glioma stem cells［J］.PLoS One,2016,11(1)：e0147717.
[15]LI J,CONDELLO S,THOMES-PEPIN J,et al.Lipid desaturation is a metabolic marker and therapeutic target of ovarian cancer stem cells［J］.Cell Stem Cell,2017,20(3)：303-314.
[16]SUN M,YANG Z.Metabolomic studies of live single cancer stem cells using mass spectrometry［J］.Anal Chem,2019,91(3)：2384-2391.
[17]VISWESWARAN M,ARFUSO F,WARRIER S,et al.Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells［J］.Stem Cells,2020,38(1)：6-14.
[18]RIVAS SERNA IM,ROMITO I,MAUGERI A,et al.A Lipidomic signature complements stemness features acquisition in liver cancer cells［J］.Int J Mol Sci,2020,21(22)：8452.
[19]BORT A,SANCHEZ BG,DE MIGUEL I,et al.Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells［J］.Mol Biol Rep,2020,47(4)：2635-2647.
[20]LIN L,DING Y,WANG Y,et al.Functional lipidomics：Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism［J］.Hepatology,2017,66(2)：432-448.
[21]MULLEN PJ,YU R,LONGO J,et al.The interplay between cell signalling and the mevalonate pathway in cancer［J］.Nat Rev Cancer,2016,16(11)：718-731.
[22]MANCINI R,NOTO A,PISANU ME,et al.Metabolic features of cancer stem cells：the emerging role of lipid metabolism［J］.Oncogene,2018,37(18)：2367-2378.
[23]IANNELLI F,ROCA MS,LOMBARDI R,et al.Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition［J］.J Exp Clin Cancer Res,2020,39：213.
[24]SHARON C,BARANWAL S,PATEL NJ,et al.Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo［J］.Oncotarget,2015,6(17)：15332-15347.
[25]BRANDI J,DANDO I,POZZA ED,et al.Proteomic analysis of pancreatic cancer stem cells：Functional role of fatty acid synthesis and mevalonate pathways［J］.J Proteomics,2017,150：310-322.
[26]SEO Y,KIM J,PARK SJ,et al.Metformin suppresses cancer stem cells through ampk activation and inhibition of protein prenylation of the mevalonate pathway in colorectal cancer［J］.Cancers(Basel),2020,12(9)：2554.
[27]EHMSEN S,PEDERSEN MH,WANG G,et al.Increased cholesterol biosynthesis is a key characteristic of breast cancer stem cells influencing patient outcome［J］.Cell Rep,2019,27(13)：3927-3938.
[28]LIANG Y,GOYETTE S,HYDER SM.Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells［J］.Breast Cancer(Dove Med Press),2017,9：487-494.
[29]KHAWAR MB,GAO H,LI W.Autophagy and lipid metabolism［J］.Adv Exp Med Biol,2019,1206：359-374.
[30]BU H,LIU D,ZHANG G,et al.AMPK/mTOR/ULK1 axis-mediated pathway participates in apoptosis and autophagy induction by oridonin in colon cancer DLD-1 cells［J］.Onco Targets Ther,2020,13：8533-8545.
[31]XIE Y,LI J,KANG R,et al.Interplay between lipid metabolism and autophagy［J］.Front Cell Dev Biol,2020,8：431.
[32]PANNUTI A,FOREMAN K,RIZZO P,et al.Targeting notch to target cancer stem cells［J］.Clin Cancer Res,2010,16(12)：3141-3152.
[33]GHANBARI-MOVAHED M,GHANBARI-MOVAHED Z,MOMTAZ S,et al.Unlocking the secrets of cancer stem cells with γ-secretase inhibitors：a novel anticancer strategy［J］.Molecules,2021,26(4)：972.
[34]AKIL A,GUTIERREZ-GARCIA AK,GUENTER R,et al.Notch signaling in vascular endothelial cells,angiogenesis,and tumor progression：an update and prospective［J］.Front Cell Dev Biol,2021,9：642352.
[35]JIANG N,ZOU C,ZHU Y,et al.HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling［J］.Theranostics,2020,10(6)：2553-2570.
[36]LI Y,WANG Z,JIN J,et al.Quercetin pretreatment enhances the radiosensitivity of colon cancer cells by targeting Notch-1 pathway［J］.Biochem Biophys Res Commun,2020,523(4)：947-953.
[37]DANDAWATE P,SUBRAMANIAM D,PANOVICH P,et al.Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway［J］.Sci Rep,2020,10(1)：1290.
[38]VILLANUEVA A,ALSINET C,YANGER K,et al.Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice［J］.Gastroenterology,2012,143(6)：1660-1669.
[39]LEE HY,HONG IS.Targeting liver cancer stem cells：an alternative therapeutic approach for liver cancer［J］.Cancers(Basel),2020,12(10)：2746.
[40]YU Y,KIM H,CHOI S,et al.Targeting a lipid desaturation enzyme,scd1,selectively eliminates colon cancer stem cells through the suppression of wnt and NOTCH signaling［J］.Cells,2021,10(1)：106.
[41]LI Y,XIAO Y,LIN HP,et al.In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis［J］.Biomaterials,2019,188：160-172.
[42]LIU W,CHEN X,WU M,et al.Recombinant Klotho protein enhances cholesterol efflux of THP-1 macrophage-derived foam cells via suppressing Wnt/β-catenin signaling pathway［J］.BMC Cardiovasc Disord,2020,20(1)：120.
[43]DAI L,ZHAO X,MA L,et al.TNF-α activates PI3K/AKT pathway to promote proliferation of SW620(Lgr5+)colon cancer stem cells［J］.Chinese Journal of Cellular and Molecular Immunology,2020,36(1)：33-41.
[44]GE JC,WANG YX,CHEN ZB,et al.Integrin alpha 7 correlates with poor clinical outcomes,and it regulates cell proliferation,apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma［J］.Cell Signal,2020,66：109465.
[45]WADHWA B,PADDAR M,KHAN S,et al.AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity［J］.Oncotarget,2020,11(45)：4178-4194.
[46]WANG W,HE S,ZHANG R,et al.ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin［J］.Biomed Pharmacother,2020,125：109940.
[47]CHOI HS,KIM SL,KIM JH,et al.The FDA-approved anti-asthma medicine ciclesonide inhibits lung cancer stem cells through hedgehog signaling-mediated SOX2 regulation［J］.Int J Mol Sci,2020,21(3)：1014.
[48]JENG KS,CHANG CF,LIN SS.Sonic hedgehog signaling in organogenesis,tumors,and tumor microenvironments［J］.Int J Mol Sci,2020,21(3)：758.